Background: Recent research has shown a possible causal relationship between ionizing radiation exposure and melanoma. Individuals with mutations in CDKN2A (cyclin-dependent kinase inhibitor 2A), the major melanoma predisposition gene, have an increased susceptibility to melanoma-promoting exposures, such as UV light. We describe a patient from a familial melanoma pedigree with 7 primary melanomas on the right side of her body, the first occurring 5 years after exposure to atmospheric nuclear bomb testing in the 1950s. Observations: Physical examination revealed phototype I skin, red hair, and 26 nevi (14 on the right and 12 on the left side of her body). One nevus was larger than 5 mm, and 2 were clinically atypical. Sequence analysis demo...
Germline mutations in CDKN2A gene predispose to melanoma with high but incomplete penetrance. Pene-t...
Mutations in the CDKN2A gene are the extremely common alteration in genetic melanoma, with presence ...
BACKGROUND: Germline mutations in CDKN2A have been associated with increased risk of melanoma and to...
Mutations in the exons of the cyclin-dependent kinase inhibitor gene CDKN2A are melanoma-predisposit...
Background Carrying the cyclin-dependent kinase inhibitor 2A (CDKN2A) germline mutations is associat...
Cyclin-dependent kinase inhibitor type 2A (CDKN2A) has been identified as a major melanoma susceptib...
<p><b>Background</b> Carrying the cyclin-dependent kinase inhibitor 2A (CDKN2A) germline mutations i...
Background Carrying the cyclin-dependent kinase inhibitor 2A (CDKN2A) germline mutations is associat...
been linked to melanoma incidence in many families with multiple cases of the disease. Previous stud...
Background: CDKN2A mutations confer a substantial risk of cutaneous melanoma; however, the magnitude...
Germ-line mutations of CDKN2A have been identified as strong risk factors for melanoma in studies of...
Cyclin-dependent kinase inhibitor 2A (CDKN2A or p16) is the major melanoma predisposition gene. In o...
A major goal in cancer prevention is to identify genetic and environmental risk factors and determin...
BackgroundGermline mutations in the CDKN2A gene have been linked to melanoma incidence in many famil...
Background: Cutaneous malignant melanoma (CMM) is an increasingly common cancer in fair-skinned peop...
Germline mutations in CDKN2A gene predispose to melanoma with high but incomplete penetrance. Pene-t...
Mutations in the CDKN2A gene are the extremely common alteration in genetic melanoma, with presence ...
BACKGROUND: Germline mutations in CDKN2A have been associated with increased risk of melanoma and to...
Mutations in the exons of the cyclin-dependent kinase inhibitor gene CDKN2A are melanoma-predisposit...
Background Carrying the cyclin-dependent kinase inhibitor 2A (CDKN2A) germline mutations is associat...
Cyclin-dependent kinase inhibitor type 2A (CDKN2A) has been identified as a major melanoma susceptib...
<p><b>Background</b> Carrying the cyclin-dependent kinase inhibitor 2A (CDKN2A) germline mutations i...
Background Carrying the cyclin-dependent kinase inhibitor 2A (CDKN2A) germline mutations is associat...
been linked to melanoma incidence in many families with multiple cases of the disease. Previous stud...
Background: CDKN2A mutations confer a substantial risk of cutaneous melanoma; however, the magnitude...
Germ-line mutations of CDKN2A have been identified as strong risk factors for melanoma in studies of...
Cyclin-dependent kinase inhibitor 2A (CDKN2A or p16) is the major melanoma predisposition gene. In o...
A major goal in cancer prevention is to identify genetic and environmental risk factors and determin...
BackgroundGermline mutations in the CDKN2A gene have been linked to melanoma incidence in many famil...
Background: Cutaneous malignant melanoma (CMM) is an increasingly common cancer in fair-skinned peop...
Germline mutations in CDKN2A gene predispose to melanoma with high but incomplete penetrance. Pene-t...
Mutations in the CDKN2A gene are the extremely common alteration in genetic melanoma, with presence ...
BACKGROUND: Germline mutations in CDKN2A have been associated with increased risk of melanoma and to...